GRO Biosciences
Boston
About GRO Biosciences
GRO Biosciences is leveraging breakthrough technologies from computational protein design and synthetic biology to develop best-in-class protein therapeutics with enhanced properties. The company has established multiple genomically recoded strains of bacteria that can incorporate non-standard amino acids into proteins to confer increased potency, stability, and targeted delivery. GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders, and autoimmunity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $92.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2024)
- Website: grobio.com
- Phone: +1 617 903 8359
Industries & Categories
Biotechnology, Health Diagnostics, Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/gro-biosciences-69020 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.